StephanieAnnChristensonMD
Pulmonology • San Francisco, CAAsthma & COPD, Critical Care Medicine, Pleural Disease
Assistant Professor
Dr. Christenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-1000Fax+1 415-353-2640
Summary
- Dr. Stephanie Christenson is a pulmonologist in San Francisco, CA. She received her medical degree from Medical College of Wisconsin and has been in practice 11 years. She specializes in asthma & copd and critical care medicine and is experienced in critical care medicine.
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
Boston University Medical CenterResidency, Internal Medicine, 2006 - 2009
Medical College of WisconsinClass of 2006
Certifications & Licensure
CA State Medical License 2010 - 2026
MA State Medical License 2009 - 2012- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Medication Adherence With Telehealthcare Medication Therapy Management Start of enrollment: 2019 Nov 18
Roles: Contact
Publications & Presentations
PubMed
- Dupilumab Improves Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS.Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, Claus F Vogelmeier, Mona Bafadhel
Chest. 2025-01-31 - 1 citationsEfficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controll...Dave Singh, Christopher E Brightling, Klaus F Rabe, MeiLan K Han, Stephanie A Christenson
The Lancet. Respiratory Medicine. 2025-01-01 - Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, Claus F Vogelmeier, Mona Bafadhel
Respiratory Medicine. 2025-01-01
Journal Articles
- Integrating Host Response and Unbiased Microbe Detection for Lower Respiratory Tract Infection Diagnosis in Critically Ill AdultsCharles Langelier, Farzad Moazed, Stephanie Christenson, Alejandra Jauregui, Michael R. Wilson, Charles Y. Chiu, Proceedings of the National Academy of Sciences
Authored Content
- Flipping the Kill SwitchJune 2017
Press Mentions
Breathe Easier During Wildfires with a DIY Air PurifierSeptember 27th, 2020- ‘Hidden Cost’ of Wildfire Smoke: Stanford Researchers Estimate up to 3,000 Indirect DeathsSeptember 24th, 2020
- Wellness Design Strategies for Addressing Wildfire Smoke and Ash in Your Homes During Covid PandemicSeptember 15th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
